Study of type I interferon in autoimmune diseases
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system, Skin clinical trials.
This study looks at a protein called type I interferon, which is often too high in people with autoimmune diseases. The goal is to better understand how it relates to these conditions, which may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 and 60 years old.
- You weigh at least 25 kg (about 55 pounds).
- You have a confirmed diagnosis of lupus, myositis, systemic sclerosis, mixed connective tissue disease, or a related genetic condition.
- You are being followed at the Hospices Civils de Lyon for your disease.
- You have not had an infection or vaccination in the past month.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a protein called interferon in the blood of people with cancer who are starting immunotherapy, and people with certain autoimmune diseases (such as lupus, Sjögren's syndrome, scleroderma, or inflammatory myopathy). The goal is to compare interferon patterns and better understand immune responses.
This study tests an experimental drug (IMSB301) for people with rare genetic conditions that cause too much type 1 interferon activity (a part of the immune system). The goal is to see if the drug is safe and can help reduce symptoms.
This study uses a blood test called mass spectrometry to look at the immune system in people with active autoimmune diseases. It aims to find patterns that could help doctors better understand and treat these conditions.
This study aims to find normal levels of interferon (a natural protein that helps fight viruses) in healthy people aged 80 and older. It will help doctors better understand what is 'normal' for older adults.
This study collects blood and tissue samples from patients with rare immune system diseases that started in childhood, and from their relatives and healthy volunteers. The goal is to build a biocollection for future research to better understand these diseases.
This study looks at people with a confirmed type 1 interferonopathy, a rare immune condition caused by a gene change. It aims to learn more about how the condition progresses over time.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.